Sphera Funds Management Ltd. Infla Rx N.V. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$2.72 - $4.04 $2.72 Million - $4.04 Million	-1,000,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.62 - $6.34 $3.62 Million - $6.34 Million	1,000,000 New	1,000,000 $3.9 Million
Q1 2020 May 14, 2020	SELL	$2.65 - $6.08 $874,500 - $2.01 Million	-330,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.2 - $4.54 $726,000 - $1.5 Million	330,000 New	330,000 $1.31 Million

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $72.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.